Potential participants will be invited to attend the study site for final screening and enrolment. The screening process includes a finger prick test to determine cholesterol levels.
Enrolled participants will complete questionnaires, have a body composition assessment, blood test and will be allocated into either the treatment of placebo group.
You will be asked to take the allocated product daily for 6 months and attend the study site every 2 months for an assessment (at the end of months 2, 4 & 6).
Each assessment will involve questionnaires, a progress interview, body composition assessment, finger prick test and blood test.